Literature DB >> 17852110

Surgical treatment of aneurysmal subarachnoid haemorrhage in the presence of 24-h endovascular availability: management and results.

W Sorteberg1, H Slettebø, P K Eide, A Stubhaug, A Sorteberg.   

Abstract

Endovascular treatment of ruptured intracranial aneurysms increasingly supersedes surgical repair. This study focuses on the management and results in 109 individuals treated surgically when both treatment modalities were available. The management principles were immediate identification of the origin of haemorrhage, early aneurysm repair, minimal brain retraction during surgery and rigorous prevention of secondary brain damage. Predominantly, aneurysms located on the middle cerebral artery and those of the posterior communicating artery were allocated to surgery. Despite of ultra-swift care, aneurysm rebleeds remained a challenge. Although one-third of the patients presented in a poor clinical grade, outcome was good with 87 (80%) of the individuals being independent, 16 (15%) being dependent and six patients (6%) dying. Results of surgical aneurysm repair are good presupposed the untiring ongoing efforts of an inter-disciplinary team of dedicated physicians and nurses.

Entities:  

Mesh:

Year:  2008        PMID: 17852110     DOI: 10.1080/02688690701593553

Source DB:  PubMed          Journal:  Br J Neurosurg        ISSN: 0268-8697            Impact factor:   1.596


  2 in total

1.  Predictors of hydrocephalus as a complication of non-traumatic subarachnoid hemorrhage: a retrospective observational cohort study in 107 patients.

Authors:  Juan Manuel Vinas Rios; Martin Sanchez-Aguilar; Thomas Kretschmer; Christian Heinen; Fatima Azucena Medina Govea; Sanchez-Rodriguez Jose Juan; Thomas Schmidt
Journal:  Patient Saf Surg       Date:  2018-05-22

2.  Impact of smoking on course and outcome of aneurysmal subarachnoid hemorrhage.

Authors:  H Slettebø; T Karic; A Sorteberg
Journal:  Acta Neurochir (Wien)       Date:  2020-07-30       Impact factor: 2.216

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.